Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT02836678
Other study ID # CEBD-2016-03-150
Secondary ID
Status Not yet recruiting
Phase Phase 2/Phase 3
First received July 11, 2016
Last updated January 13, 2017
Start date January 2017
Est. completion date September 2019

Study information

Verified date January 2017
Source Cairo University
Contact Maged Anis, Assisstant lecturer
Phone 00201000618605
Email magedwadie@hotmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The effect of adding Nanobone on horizontal bone gain in ridge splitting.


Description:

In cases of a very narrow ridge, One of the augmentation protocols is alveolar ridge-splitting techniques (RST) or alveolar ridge expansion techniques with simultaneous implant insertion. The piezoelectric surgical devices implemented for conducting bone osteotomy through the use of micrometric ultrasonic vibrations have been widely used in recent years in maxillofacial surgery. Its biggest advantages are that it allows for cutting with micrometric sensitivity while cutting hard tissues, it offers a clear vision of the surgical site due to its cavitation effect, it does not cause any damage to the soft tissues while performing these cuts, and that the bone tissue heals more quickly and seamlessly, after the cuts made by piezosurgery device. The fully synthetic bone substitute, NanoBone® (Artoss, Rostock, Germany), which will be applied in this clinical study, is basically a nanocrystalline hydroxyapatite embedded in a silica gel matrix, achieved by means of specific sol-gel techniques. Features such as interconnecting pores on the nanoscale, the open SiOH or SiO groups of polysilicic acid, its large internal surface, and the high porosity of this biomaterial are all related to the calcification processes observed within the implantation bed. While the HA component is responsible for NanoBone osteoconductive properties, the silica component is believed to induce connective tissue formation, osteoblast proliferation, bone matrix mineralization, and calcification, thus combining osteoconductive and osteoinductive properties. This phenomenon is associated with the rearrangement of the silica matrix, which could be observed in vivo.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 40
Est. completion date September 2019
Est. primary completion date September 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- Age: 18-70.

- Patients with an edentulous site in maxilla.

- Ridge width of <6mm at the edentulous site.

- Ridge height of >9mm at the edentulous site.

- Patients who are compliant to oral hygiene measures for 4 weeks.

- Patient consent approval and signing.

Exclusion Criteria:

- Smokers.

- Systemic disease that contraindicates implant placement or surgical procedures.

- No or poor patient's compliance.

- History of radio or chemo-therapy.

- Psychological problems.

- Pathology at the site of intervention.

- Pregnancy.

- Insufficient crown height space or mesio-distal dimension that contradict the placement of a dental implant.

Study Design


Related Conditions & MeSH terms


Intervention

Biological:
Ridge splitting, immediate implant, Nanobone with PRF.
Dental implant (is a surgical component that interfaces with the bone of the jaw or skull to support a dental prosthesis). Alloplast bone graft material (Nanobone) PRF platelet rich fibrin. (second-generation Platelet rich plasma where autologous platelets and leucocytes are present in a complex fibrin matrix to accelerate the healing of soft and hard tissue).
Ridge splitting, immediate implantand PRF.
Dental implant (is a surgical component that interfaces with the bone of the jaw or skull to support a dental prosthesis). PRF platelet rich fibrin. (second-generation Platelet rich plasma where autologous platelets and leucocytes are present in a complex fibrin matrix to accelerate the healing of soft and hard tissue).

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

References & Publications (2)

Gerber, T., Holzhüter, G., Knoblich, B., Dörfling, P., Bienengräber, V., & Henkel, K. O. (2000). Development of bioactive sol-gel material template for in vitro and in vivo synthesis of bone material. Journal of Sol-Gel Science and Technology, 19(1-3), 441-445. http://doi.org/10.1023/A:10087995

Porter AE, Patel N, Skepper JN, Best SM, Bonfield W. Effect of sintered silicate-substituted hydroxyapatite on remodelling processes at the bone-implant interface. Biomaterials. 2004 Jul;25(16):3303-14. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Horizontal bone gain in millimeters using Cone beam computed tomography 5 month
Secondary Post-operative pain Using Numerical rating scale 2 weeks
Secondary Post-operative swelling Using Descriptive 4-point scale of swelling 2 weeks